1. L-type amino acid transporter (LAT) 1 expression in 18 F-FET-negative gliomas.
- Author
-
Vettermann FJ, Diekmann C, Weidner L, Unterrainer M, Suchorska B, Ruf V, Dorostkar M, Wenter V, Herms J, Tonn JC, Bartenstein P, Riemenschneider MJ, and Albert NL
- Abstract
Background: O-(2-[
18 F]-fluoroethyl)-L-tyrosine (18 F-FET) is a highly sensitive PET tracer for glioma imaging, and its uptake is suggested to be driven by an overexpression of the L-type amino-acid transporter 1 (LAT1). However, 30% of low- and 5% of high-grade gliomas do not present enhanced18 F-FET uptake at primary diagnosis ("18 F-FET-negative gliomas") and the pathophysiologic basis for this phenomenon remains unclear. The aim of this study was to determine the expression of LAT1 in a homogeneous group of newly diagnosed18 F-FET-negative gliomas and to compare them to a matched group of18 F-FET-positive gliomas. Forty newly diagnosed IDH-mutant astrocytomas without 1p/19q codeletion were evaluated (n = 2018 F-FET-negative (tumour-to-background ratio (TBR) < 1.6), n = 2018 F-FET-positive gliomas (TBR > 1.6)). LAT1 immunohistochemistry (IHC) was performed using SLC7A5/LAT1 antibody. The percentage of LAT1-positive tumour cells (%) and the staining intensity (range 0-2) were multiplied to an overall score (H-score; range 0-200) and correlated to PET findings as well as progression-free survival (PFS)., Results: IHC staining of LAT1 expression was positive in both,18 F-FET-positive as well as18 F-FET-negative gliomas. No differences were found between the18 F-FET-negative and18 F-FET-positive group with regard to percentage of LAT1-positive tumour cells, staining intensity or H-score. Interestingly, the LAT1 expression showed a significant negative correlation with the PFS (p = 0.031), whereas no significant correlation was found for TBRmax , neither in the overall group nor in the18 F-FET-positive group only (p = 0.651 and p = 0.140)., Conclusion: Although LAT1 is reported to mediate the uptake of18 F-FET into tumour cells, the levels of LAT1 expression do not correlate with the levels of18 F-FET uptake in IDH-mutant astrocytomas. In particular, the lack of tracer uptake in18 F-FET-negative gliomas cannot be explained by a reduced LAT1 expression. A higher LAT1 expression in IDH-mutant astrocytomas seems to be associated with a short PFS. Further studies regarding mechanisms influencing the uptake of18 F-FET are necessary., (© 2021. The Author(s).)- Published
- 2021
- Full Text
- View/download PDF